Under the partnership, Hackensack’s office of innovation will work with the company to develop an AI tool that can detect early-stage carcinoma in situ, according to an April 19 press release from Hackensack Meridian Health.
Nitin Yerram, MD, director of urologic oncology at Hackensack University Medical Center, will spearhead the initiative.
The aim is to integrate the tool into existing clinical workflows.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
